Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019

SELL
$2.56 - $4.48 $3,691 - $6,460
-1,442 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$2.98 - $6.86 $4,297 - $9,892
1,442 New
1,442 $4,000
Q3 2018

Nov 14, 2018

SELL
$5.36 - $7.83 $1,457 - $2,129
-272 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$5.97 - $9.58 $1,623 - $2,605
272 New
272 $2,000

About T2 Biosystems, Inc.


  • Ticker TTOO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 7,050,850
  • Market Cap $3.53M
  • Description
  • T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...
More about TTOO
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.